Hainan Honz Pharmaceutical Company Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 540

Employees

  • Stock Symbol
  • 300086

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.61
  • (As of Friday Closing)

Hainan Honz Pharmaceutical Company General Information

Description

Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.

Contact Information

Website
www.honz.com.cn
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2601 26/F Dongshan Plaza No. 69
  • Xianlie Zhonglu
  • Guangzhou, GuangDong 510095
  • China
+86
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • 2601 26/F Dongshan Plaza No. 69
  • Xianlie Zhonglu
  • Guangzhou, GuangDong 510095
  • China
+86

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hainan Honz Pharmaceutical Company Stock Performance

As of 20-Nov-2026, Hainan Honz Pharmaceutical Company’s stock price is $0.61. Its current market cap is $276M with 455M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.61 $0.64 $0.60 - $2.16 $276M 455M 15.6M -$0.07

Hainan Honz Pharmaceutical Company Financials Summary

As of 30-Sep-2026, Hainan Honz Pharmaceutical Company has a trailing 12-month revenue of $48.7M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 428,829 846,249 366,559 426,577
Revenue 48,688 64,817 65,435 97,425
EBITDA (29,300) (24,194) (19,524) 12,736
Net Income (30,368) (32,002) (30,026) (1,928)
Total Assets 248,681 255,979 270,749 302,120
Total Debt 66,752 63,844 69,958 70,767
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hainan Honz Pharmaceutical Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hainan Honz Pharmaceutical Company Investments & Acquisitions (3)

Hainan Honz Pharmaceutical Company’s most recent deal was a Joint Venture with Hainan Jointown Caplinpoint Pharmaceutical Company for . The deal was made on 06-Aug-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hainan Jointown Caplinpoint Pharmaceutical Company 06-Aug-2018 Joint Venture Pharmaceuticals
Kangzhi Hospital Management 20-Jun-2018 Merger/Acquisition Hospitals/Inpatient Services
Guangdong Yuanning Pharmaceutical 19-Aug-2014 Merger/Acquisition Drug Delivery
To view Hainan Honz Pharmaceutical Company’s complete investments and acquisitions history, request access »

Hainan Honz Pharmaceutical Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Hainan Honz Pharmaceutical Company’s complete esg history, request access »

Hainan Honz Pharmaceutical Company Exits (1)

Hainan Honz Pharmaceutical Company’s most recent exit was on 20-Jun-2018 from Kangzhi Hospital Management. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Kangzhi Hospital Management 20-Jun-2018 Completed
To view Hainan Honz Pharmaceutical Company’s complete exits history, request access »

Hainan Honz Pharmaceutical Company FAQs

  • When was Hainan Honz Pharmaceutical Company founded?

    Hainan Honz Pharmaceutical Company was founded in 1994.

  • Where is Hainan Honz Pharmaceutical Company headquartered?

    Hainan Honz Pharmaceutical Company is headquartered in Guangzhou, China.

  • What is the size of Hainan Honz Pharmaceutical Company?

    Hainan Honz Pharmaceutical Company has 540 total employees.

  • What industry is Hainan Honz Pharmaceutical Company in?

    Hainan Honz Pharmaceutical Company’s primary industry is Drug Discovery.

  • Is Hainan Honz Pharmaceutical Company a private or public company?

    Hainan Honz Pharmaceutical Company is a Public company.

  • What is Hainan Honz Pharmaceutical Company’s stock symbol?

    The ticker symbol for Hainan Honz Pharmaceutical Company is 300086.

  • What is the current stock price of Hainan Honz Pharmaceutical Company?

    As of 20-Nov-2026 the stock price of Hainan Honz Pharmaceutical Company is $0.61.

  • What is the current market cap of Hainan Honz Pharmaceutical Company?

    The current market capitalization of Hainan Honz Pharmaceutical Company is $276M.

  • What is Hainan Honz Pharmaceutical Company’s current revenue?

    The trailing twelve month revenue for Hainan Honz Pharmaceutical Company is $48.7M.

  • What is Hainan Honz Pharmaceutical Company’s annual earnings per share (EPS)?

    Hainan Honz Pharmaceutical Company’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process